In a BPC-157 and TB-500 stack, it is common to keep the BPC-157 dose at the standard 250-500 mcg range, as its action is highly localized, but reduce the TB-500 dose to the lower end of the range (e.g., 2.5 mg per week) for systemic support
This sustained sensitivity may explain why some individuals report consistent benefits from low doses maintained over many months
Key considerations for injectable formulations: High bioavailability: Immediate systemic absorption allows effects to be felt substantially quicker than with oral supplements
For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
